November 2, 2022
(press release)
–
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPhI Worldwide in Frankfurt, Germany to showcase its leadership and expertise on industry challenges and trends in packaging and containment. "As a leader in the healthcare industry for nearly a hundred years, West recognizes the needs for complete system solutions to support more complex molecules and combination products, along with meeting increasing regulatory requirements. To support this effort, we recently announced a collaboration with Corning," said Chris Ryan, Vice President, Containment and Glass Systems at West. "At this year's conference, we look forward to sharing some recent data that highlights our advancements in solutions for lyophilization as well as our NovaPure® components with Valor® Glass technology for low temperature closure container integrity." West experts will hold two featured speaking sessions: Title: Design of a New Elastomer Formulation for Lyophilization Applications Title: Selection of a Primary Container Closure System Capable of Maintaining Closure Integrity during Cold Storage at -80°C For more information about West, please visit our website: www.westpharma.com. For more information about CPhI Worldwide, please visit: CPHI Frankfurt | Where Business Meets Science About West West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With approximately 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 45 billion components and devices each year. Headquartered in Exton, Pennsylvania, and in business for nearly a century, West in its fiscal year 2021 generated $2.83 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com. All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted. SOURCE West Pharmaceutical Services, Inc. Primary Media Contact: Cynthia Salitsky, Director, External Global Communications, +1-484-983-4893, Cynthia.Salitsky@westpharma.com, Secondary Media Contact: Eileen Falchetta, Senior Manager, External Global Communications, +1-484-354-7857, Eileen.Falchetta@westpharma.com
Speaker: Francis Carroll, Specialist Technical Customer Support
Session: Tuesday 1 November, 12:00– 12:25 PM
Speaker: Jennifer Roark, Technology Manager, Container Closure Integrity
Session: Tuesday 1 November, 4:00– 4:25 PM
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
